The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters MedShadow Foundation Beyond the Headlines: FDA Warning Letters to GLP 1 Compounders Spencer Fane People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines